Karyopharm Therapeutics reported $-83132000 in Equity Capital and Reserves for its second fiscal quarter of 2021.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Equity Capital And Reserves Change
Acceleron Pharma XLRN:US $ 763.03M 47.8M
Amgen AMGN:US $ 8247M 1087M
Astrazeneca AZN:US $ 15676M 1246M
AstraZeneca AZN:LN 15676M 1246M
Avrobio Inc AVRO:US $ 220.99M 11.94M
Biocryst Pharmaceuticals BCRX:US $ -106.08M 31.09M
Bristol Myers Squibb BMY:US $ 36808M 797M
Eli Lilly And LLY:US $ 6444.4M 454.3M
Enanta Pharmaceuticals ENTA:US $ 417.85M 18.18M
Epizyme EPZM:US $ 67.63M 55.4M
GlaxoSmithKline GSK:LN 15377M 512M
Karyopharm Therapeutics KPTI:US $ -83132000 43.49M
Macrogenics MGNX:US $ 319.04M 31.49M
Mirati Therapeutics MRTX:US $ 1128.92M 130.49M
Nektar Therapeutics NKTR:US $ 904.98M 89.53M
Novartis NVS:US $ 54042M 3519M
Novartis NOVN:VX SF 54042M 3519M
Regeneron Pharmaceuticals REGN:US $ 15127.3M 3150.3M
Sangamo Biosciences SGMO:US $ 445.46M 24.9M
Takeda 4502:JP Y 5299774M 126737M
Tg Therapeutics TGTX:US $ 383.13M 62.16M
Ultragenyx Pharmaceutical RARE:US $ 972.17M 82.41M
Xencor XNCR:US $ 646.94M 63.33M
YTE INCY:US $ 2935.86M 208.02M